Can-Fite BioPharma Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
Can-Fite BioPharma Ltd. (CANF) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $3.00 per share as of 2021-12-31, per its 20-F filed 2022-03-24.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2022-03-24
- 2021-04-13: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price 0.25 ILS/shares.
ILS/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2021-04-13 | 0.25 ILS/shares 6-K · filed 2021-08-26 |
USD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2021-12-31 | $3.00 20-F · filed 2022-03-24 |